Vahid Shaygannejad

InstitutionIsfahan University of Medical sciences
AddressIsfahan
Iran
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 2 publications in May 2020 and April 2021
    All Publications
    Bar chart showing 103 publications over 15 distinct years, with a maximum of 23 publications in 2013
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Motahharynia A, Naghavi S, Shaygannejad V, Adibi I. Paraparesis due to aortic thromboembolism as a rare complication of COVID-19 infection. J Vasc Surg. 2021 09; 74(3):1047. PMID: 34425947.
      Citations:    Fields:    Translation:Humans
    2. Barzegar M, Mirmosayyeb O, Gajarzadeh M, Afshari-Safavi A, Nehzat N, Vaheb S, Shaygannejad V, Maghzi AH. COVID-19 Among Patients With Multiple Sclerosis: A Systematic Review. Neurol Neuroimmunol Neuroinflamm. 2021 07; 8(4). PMID: 34016734.
      Citations: 9     Fields:    Translation:Humans
    3. Shaygannejad V, Mirmosayyeb O, Nehzat N, Ghajarzadeh M. Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage. Neurol Sci. 2021 Jul; 42(7):2615-2618. PMID: 33860396.
      Citations:    Fields:    Translation:HumansPHPublic Health
    4. Barzegar M, Vaheb S, Mirmosayyeb O, Afshari-Safavi A, Nehzat N, Shaygannejad V. Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study. Mult Scler Relat Disord. 2021 Jul; 52:102947. PMID: 33979771.
      Citations: 4     Fields:    Translation:Humans
    5. Shaygannejad V, Afshari-Safavi A, Hatef B. Assessment of mental health, knowledge, and attitude of patients with multiple sclerosis and neuromyelitis optica spectrum disorder in response to 2019 novel coronavirus. Neurol Sci. 2021 Jul; 42(7):2891-2901. PMID: 33219424.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    6. Mirmosayyeb O, Vaheb S, Barzegar M, Shaygannejad V, Bonavita S, Ghajarzadeh M. Screening neuromyelitis optica patients for COVID-19 infection. Autoimmun Rev. 2020 11; 19(11):102669. PMID: 32942032.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    7. Ramezani N, Adibi I, Mirmosayyeb O, Shaygannejad V. MS Care in Novel Coronavirus 19 Pandemic. Int J Prev Med. 2020; 11:98. PMID: 33042495.
      Citations:    
    8. Barzegar M, Mirmosayyeb O, Ghajarzadeh M, Nehzat N, Vaheb S, Shaygannejad V, Vosoughi R. Characteristics of COVID-19 disease in multiple sclerosis patients. Mult Scler Relat Disord. 2020 10; 45:102276. PMID: 32652473.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    9. Ghajarzadeh M, Mirmosayyeb O, Barzegar M, Nehzat N, Vaheb S, Shaygannejad V, Maghzi AH. Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic. Mult Scler Relat Disord. 2020 08; 43:102222. PMID: 32464586.
      Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
    10. Barzegar M, Mirmosayyeb O, Nehzat N, Sarrafi R, Khorvash F, Maghzi AH, Shaygannejad V. COVID-19 infection in a patient with multiple sclerosis treated with fingolimod. Neurol Neuroimmunol Neuroinflamm. 2020 07; 7(4). PMID: 32371550.
      Citations: 33     Fields:    Translation:HumansCellsPHPublic Health